Alterity Therapeutics (Alterity Therapeutics) PB Ratio : 0.60 (As of Apr. 25, 2024)

View and export this data going back to 2002. Start your Free Trial

What is Alterity Therapeutics PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-04-25), Alterity Therapeutics's share price is $2.26. Alterity Therapeutics's Book Value per Share for the fiscal year that ended in Jun. 2023 was $3.77. Hence, Alterity Therapeutics's PB Ratio of today is 0.60.

The historical rank and industry rank for Alterity Therapeutics's PB Ratio or its related term are showing as below:

ATHE' s PB Ratio Range Over the Past 10 Years
Min: 0.05 Med: 0.65 Max: 66.84
Current: 0.58

During the past 13 years, Alterity Therapeutics's highest PB Ratio was 66.84. The lowest was 0.05. And the median was 0.65.

ATHE's PB Ratio is ranked better than
87.49% of 1311 companies
in the Biotechnology industry
Industry Median: 2.37 vs ATHE: 0.58

During the past 12 months, Alterity Therapeutics's average Book Value Per Share Growth Rate was -40.00% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 8.70% per year. During the past 5 years, the average Book Value Per Share Growth Rate was -15.70% per year. During the past 10 years, the average Book Value Per Share Growth Rate was -19.20% per year.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Alterity Therapeutics was 56.60% per year. The lowest was -51.90% per year. And the median was -18.70% per year.

Back to Basics: PB Ratio

Alterity Therapeutics PB Ratio Historical Data

The historical data trend for Alterity Therapeutics's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alterity Therapeutics PB Ratio Chart

Alterity Therapeutics Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

PB Ratio

Get a 7-Day Free Trial

1.63

4.17

1.94

0.98

0.74

Alterity Therapeutics Quarterly Data
	Dec17	Jun18	Dec18	Jun19	Sep19	Dec19	Jun20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
PB Ratio	Get a 7-Day Free Trial															0.74	-	0.74	-	-

Competitive Comparison of Alterity Therapeutics's PB Ratio

For the Biotechnology subindustry, Alterity Therapeutics's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Alterity Therapeutics's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Alterity Therapeutics's PB Ratio distribution charts can be found below:

* The bar in red indicates where Alterity Therapeutics's PB Ratio falls into.

Alterity Therapeutics PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Alterity Therapeutics's PB Ratio for today is calculated as follows:

PB Ratio	=	Share Price	/	Book Value per Share (A: Jun. 2023)
	=	2.26	/	3.765
	=	0.60

It can also be calculated from the numbers for the whole company:

PB Ratio

Market Cap

(Total Stockholders Equity

Preferred Stock)

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.

Alterity Therapeutics (NAS:ATHE) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.

Alterity Therapeutics PB Ratio Related Terms

Thank you for viewing the detailed overview of Alterity Therapeutics's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Alterity Therapeutics (Alterity Therapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alterity Therapeutics Ltd (NAS:ATHE) » Definitions » PB Ratio

Comparable Companies

Traded in Other Exchanges

PBN:Germany ATH:Australia

Address

350 Collins Street, Level 14, Melbourne, VIC, AUS, 3000

Website

https://www.alteritytherapeutics.com

Alterity Therapeutics Ltd is active in the healthcare domain. The company is engaged in research collaborations for the treatment of Parkinsonian movement disorders, Alzheimer's disease, Huntington disease, and other neurodegenerative disorders. The company's lead drug candidate-PBT2 is being developed for the treatment of Alzheimer's and Huntington's diseases. It has also advanced a drug candidate for Parkinson's disease and other movement disorders (ATH434). The Group operated in one segment, being researching and developing Parkinsonian and other neurodegenerative disorders.